PecFent 100 micrograms/spray nasal spray, solution - Summary of Product Characteristics (SmPC) - (emc)
FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
PecFent 400 micrograms/spray nasal spray, solution - Summary of Product Characteristics (SmPC) - (emc)
![Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning](https://www.degruyter.com/document/doi/10.1016/j.sjpain.2015.12.001/asset/graphic/j.sjpain.2015.12.001_graphic_001.jpg)